Target Price | $79.05 |
Price | $39.35 |
Potential |
100.89%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target PROCEPT BioRobotics 2026 .
The average PROCEPT BioRobotics target price is $79.05.
This is
100.89%
register free of charge
$94.50
140.15%
register free of charge
$60.60
54.00%
register free of charge
|
|
A rating was issued by 19 analysts: 15 Analysts recommend PROCEPT BioRobotics to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the PROCEPT BioRobotics stock has an average upside potential 2026 of
100.89%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 224.50 | 331.15 |
64.84% | 47.51% | |
EBITDA Margin | -40.70% | -11.96% |
47.39% | 70.62% | |
Net Margin | -40.72% | -25.84% |
47.64% | 36.54% |
15 Analysts have issued a sales forecast PROCEPT BioRobotics 2025 . The average PROCEPT BioRobotics sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an PROCEPT BioRobotics EBITDA forecast 2025. The average PROCEPT BioRobotics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 PROCEPT BioRobotics Analysts have issued a net profit forecast 2025. The average PROCEPT BioRobotics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.75 | -1.54 |
21.88% | 12.00% | |
P/E | negative | |
EV/Sales | 5.86 |
15 Analysts have issued a PROCEPT BioRobotics forecast for earnings per share. The average PROCEPT BioRobotics EPS is
This results in the following potential growth metrics and future valuations:
PROCEPT BioRobotics...
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 07 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 07 2025 |
B of A Securities |
Locked
➜
Locked
|
Locked | Apr 25 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 26 2025 |
Analyst Rating | Date |
---|---|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 07 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 07 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 15 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 07 2025 |
Locked
B of A Securities:
Locked
➜
Locked
|
Apr 25 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.